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Shigella flexneri contact with enterocytes induces a burst of protein secretion via its type III secretion
apparatus (TTSA) as an initial step in cellular invasion. We have previously reported that IpaD is positioned
at the TTSA needle tip (M. Espina et al., Infect. Immuno. 74:4391–4400, 2006). From this position, IpaD senses
small molecules in the environment to control the presentation of IpaB to the needle tip. This step occurs
without type III secretion induction or IpaC recruitment to the S. flexneri surface. IpaC is then transported to
the S. flexneri surface when target cell lipids are added, and this event presumably mimics host cell contact.
Unlike IpaB mobilization, IpaC surface presentation is closely linked to secretion induction. This study
demonstrates that sphingomyelin and cholesterol are key players in type III secretion induction and that they
appear to interact with IpaB to elicit IpaC presentation at the TTSA needle tip. Furthermore, IpaB localization
at the needle tip prior to membrane contact provides the optimal set of conditions for host cell invasion. Thus,
the S. flexneri type III secretion system can be induced in a stepwise manner, with the first step being the stable
association of IpaD with the needle tip, the second step being the sensing of small molecules by IpaD to
mobilize IpaB to the tip, and the third step being the interaction of lipids with IpaB to induce IpaC localization
at the needle tip concomitant with translocon insertion into the host membrane and type III secretion
induction.
Shigella flexneri, the causative agent of shigellosis, is responsible
for more than 1 million deaths each year, especially among
children in developing regions (www.who.int/vaccines-documents
/DocsPDF99/www9947.pdf). Once ingested, S. flexneri crosses
M cells and passes into the underlying gut-associated lymphoid
tissues of the colon (20), where it kills macrophages (29) and
then invades epithelial cells by macropinocytosis (17). The S.
flexneri invasive phenotype localizes genetically to a 31-kb re-
gion of its large virulence plasmid and is absolutely tied to its
type III secretion system (TTSS) (6, 23).
TTSSs are used by numerous gram-negative bacteria to in-
troduce bacterially derived effector proteins into the mem-
brane and cytoplasm of a target cell, resulting in the subversion
of normal cell functions (8). Linking the bacterium and host
cell in this process is the type III secretion apparatus (TTSA),
which structurally resembles a molecular needle and syringe.
The system is controlled by a basal body (the syringe) that
spans both bacterial membranes and an external needle that
provides a conduit from the basal body to the sensory needle
tip complex (8, 28). The needle in S. flexneri is comprised of a
polymer of MxiH and is approximately 50 nm long and 7 nm in
diameter, with a central channel that is about 2.5 nm in diam-
eter (5). At the top of the MxiH needle resides the tip protein
IpaD, most likely as a pentamer, which serves as an environ-
mental sensor for the MxiH-IpaD tip complex (4, 7). When the
presence of bile salts such as deoxycholate (DOC) is sensed by
IpaD, the first translocator protein, IpaB, is mobilized to the
TTSA needle tip to form an MxiH-IpaD-IpaB ternary com-
plex. At this stage, the TTSA structure is primed for subse-
quent host cell contact (19, 24). In previous studies IpaC had
not been found to localize to the S. flexneri surface of the
log-phase bacterium (7, 19).
As a next step in describing the process of type III secretion,
we show here that liposomes trigger mobilization of IpaC to
the needle tip complex, where it is immediately inserted into
the host cell membrane, along with IpaB, to complete the
TTSA conduit into the host cell just prior to initiating host
cytoskeleton rearrangements. IpaC is most efficiently recruited
to the S. flexneri surface with a defined liposome composition
that includes phospholipids, sphingomyelin (SM), and choles-
terol (Chol). Furthermore, IpaC recruitment occurs concomi-
tantly with induction of type III secretion of IpaB, IpaC, and
IpaD into the S. flexneri culture supernatant. It thus appears
that IpaB mobilization to the S. flexneri TTSA needle tip rep-
resents a second discrete step in TTSA assembly, with the final
third step being IpaC recruitment to the needle tip, which
occurs after IpaB contacts and inserts into the host cell mem-
brane.
MATERIALS AND METHODS
Materials. The S. flexneri ipaC null mutant (strain SF621) and ipaA-ipgD null
mutant were from P. J. Sansonetti (Institut Pasteur, Paris, France) (18). The S.
flexneri mxiH null strain was generated by A. Allaoui (Brussels, Belgium) (3).
Antibodies were from E. V. Oaks, Walter Reed Army Institute for Research
(Silver Springs, MD). Sheep and goat red blood cells were from the Colorado
Serum Company (Denver, CO). Alexa Fluor-labeled secondary antibodies were
from Molecular Probes (Eugene, OR). DOPC (1,2-dioleoyl-sn-glycero-3-phos-
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phocholine), DOPG {1,2-dioleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)]}, and
SM were from Avanti Polar-Lipids, Inc. (Alabaster, AL). Hank’s balanced salt
solution (HBSS) and Chol were from the Sigma Chemical Co. (St. Louis, MO).
Minimum essential medium with Earle’s salts (MEME) was from Gibco-BRL.
All other chemicals were reagent grade.
Preparation of liposomes from sheep erythrocytes. Liposomes were prepared
from sheep erythrocytes as described previously (2, 12). Briefly, 15 ml of eryth-
rocyte suspension was collected by centrifugation, washed three times with 10
mM sodium phosphate (pH 7.0)–150 mM NaCl (phosphate-buffered saline
[PBS]), and subjected to hypotonic lysis with deionized water. The resulting
erythrocyte ghosts were collected by centrifugation and washed four times with
PBS. The ghosts were used directly to assay for IpaC mobilization to the S.
flexneri surface, or the lipids were extracted with chloroform and methanol (2).
The extracted lipid fraction was then dried under vacuum conditions and resus-
pended in 2 ml of PBS. To ensure that the procedure resulted in liposome
preparations of uniform size, the suspension was pulse sonicated, centrifuged,
and extruded 10 times at 45°C through a 100-nm-pore-size membrane (1).
Preparation of liposomes having a defined composition. Commercial lipids
were resuspended in chloroform and mixed in the following ratios to achieve 1
mg/ml: (i) DOPC; (ii) DOPG:DOPC (1:3); (iii) SM:DOPC (1:3); (iv) Chol:
DOPC (1:3); and (v) SM:Chol:DOPC (1:1:2). Lipid mixtures were dried under
vacuum conditions. The resulting lipid films were resuspended in 1 ml of PBS,
sonicated to form liposomes, and extruded through a 100-nm-pore-size mem-
brane as described above (1).
Incubation of S. flexneri with liposomes. To determine the ability of liposomes
to promote the mobilization of IpaC to the S. flexneri TTSA needle tip, a
modification of the standard contact-mediated hemolysis assay was used (21, 22).
Briefly, S. flexneri were grown to the log phase at 37°C in tryptic soy broth (TSB)
containing 0.1% DOC and 50 g/ml kanamycin (100 g/ml ampicillin was in-
cluded when appropriate). The bacteria were collected, resuspended in 200 l of
PBS, and combined with either 200 l of erythrocyte-derived liposomes or
defined liposomes. After 90 min at 37°C, the bacteria and associated proteins
were fixed with formaldehyde and the reaction was quenched with glycine. The
presence of IpaC on the S. flexneri surface was determined by immunofluores-
cence microscopy. To reduce exposure risks, an ipaA-ipgD null strain was initially
used for many of these experiments. This strain has a wild-type phenotype for
secretion control, invasion, and hemolysis (18). To determine the region of IpaC
required for its recruitment to and maintenance at the S. flexneri TTSA needle
tip, previously characterized ipaC mutants of S. flexneri ipaC null strain SF621
were used (21, 26).
Fluorescence microscopy. Bacteria were dried on a coverslip, blocked with 1%
bovine serum albumin in PBS, and immunolabeled with rabbit polyclonal anti-
MxiH, anti-IpaB, and/or mouse monoclonal anti-IpaC antibodies. Alexa Fluor
488 goat anti-rabbit and/or Alexa Fluor 488 or 568 anti-mouse immunoglobulin
G (IgG) was utilized for fluorescence detection. Imaging was performed using an
Olympus IX-81 microscope equipped with 488- and 568-nm-excitation laser
lines, a 60 objective (numerical aperture, 1.45), and a Hamamatsu electronic
microscopy charge-coupled device. Phase-contrast images were also obtained.
Student’s t tests were performed using the resulting data, as needed.
Electron microscopy. When mxiH is subcloned behind the inducible lac pro-
moter of pRK2 and protein expression is induced in mxiH null mutant SH116
(giving mxiH pRK2/SH116), long needles (some more than 300 nm in length) are
generated, making them more readily visible on the bacterial surface (11, 25).
This strain was grown at 37°C in TSB containing 100 g/ml ampicillin, 50 g/ml
kanamycin, 0.1% DOC, and 1 mM IPTG (isopropyl--D-thiogalactopyranoside).
Cells were harvested by centrifugation, resuspended in the appropriate liposome
preparation, and incubated for 90 min at 37°C. Glutaraldehyde was added to
achieve a final concentration of 4%, and the samples were placed on either
carbon-Formvar or holey-carbon electronic microscopy grids. The samples were
treated with rabbit polyclonal anti-IpaB antibodies followed by 5-nm-diameter
gold-labeled goat anti-rabbit IgG F(ab)2 and with mouse monoclonal anti-IpaC
antibodies followed by 10-nm-diameter gold-labeled anti-mouse IgG F(ab)2.
Negative staining with 2% uranyl acetate permitted visualization of the samples.
Samples were imaged using an FEI Tecnai G2 field emission transmission elec-
tron microscope at an electron acceleration voltage of 200 KeV.
Induced secretion of TTSS proteins. Induction of type III secretion in S.
flexneri can be examined by measuring protein secretion following the addition of
Congo red (CR). CR stimulates a rapid burst of protein secretion by the S.
flexneri TTSS, thus mimicking the response seen upon host cell contact (11).
Bacteria were grown in a single broth culture, and then the culture was divided
equally for incubation with liposomes or other treatments to ensure that identical
numbers of bacteria were represented in the Western blot analysis. After a
20-min incubation with various liposome preparations, bacteria were removed by
centrifugation. The resulting supernatant fraction from identical numbers of cells
was assessed for IpaB, IpaC, and IpaD secretion by Western blot analysis using
rabbit anti-IpaC antibodies and mouse monoclonal anti-IpaB and -IpaD anti-
bodies and the corresponding Alexa Fluor 680 goat anti-mouse IgG and Alexa
Fluor 800 goat anti-rabbit IgG (Molecular Probes, Eugene, OR). Images were
obtained and relative protein ratios quantified using an Odyssey Infrared Imager
(LI-COR, Lincoln, NE).
Invasion of cultured HeLa cells. The ability of S. flexneri to invade cultured
cells was measured by a modified gentamicin protection method (11). To assess
the impact of IpaB localization on invasion, these assays were performed using
HBSS to avoid the effects that MEME has on tip complex composition (data not
shown). Bacteria for these assays were grown under several sets of conditions,
including those that promote localization of IpaB or of IpaB plus IpaC on the
bacterial surface. Student’s t tests were performed using the resulting data as
needed.
RESULTS
IpaC can be induced to localize to the S. flexneri surface as
part of the TTSA needle tip complex. We have previously
shown that IpaD alone localizes to the TTSA needle tip of S.
flexneri in the log phase in TSB. IpaB colocalizes with IpaD
only when S. flexneri bacteria are incubated in the presence of
DOC during the log phase; however, IpaC has not previously
been observed on the S. flexneri surface (7, 19, 24). Because
IpaC is required for translocon pore formation and contact-
mediated hemolysis, it is likely that it must become a part of
the tip complex upon contact with erythrocytes. Therefore, the
contact-mediated hemolysis assay was modified to visualize
IpaC on the bacterial surface. Bacteria were grown in the
presence of DOC to the log phase and then incubated with the
erythrocytes. Indeed, mouse anti-IpaC antibodies and Alexa
Fluor 488 goat anti-mouse IgG detected IpaC on the S. flexneri
surface; however, the released hemoglobin interfered with mi-
croscopy (data not shown). Confirmation of this event was
achieved when erythrocyte ghosts were used. Under these con-
ditions, IpaC could be clearly visualized on the surface of 25%
of the observed S. flexneri bacteria (Fig. 1B). Furthermore,
IpaC was visible only in areas where IpaB was also detected
(Fig. 1D), indicating colocalization.
FIG. 1. Immunofluorescence microscopy was used to demonstrate
the presence of IpaC on the S. flexneri surface following incubation
with sheep erythrocyte ghosts. Panel A shows an immunofluorescence
micrograph of IpaB localization. IpaC localization is seen in panel B,
and a merged image composed of the images presented in panels A
and B is seen in panel D. Panel C shows a differential interference
contrast micrograph.
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The central hydrophilic region of IpaC may be important for
its maintenance at the S. flexneri surface. We have previously
shown that IpaC possesses distinct functional domains (9, 21,
26). Therefore, we sought to use these constructs to determine
the regions within IpaC that are required for its stable main-
tenance at the S. flexneri surface. Erythrocyte liposomes were
used in these experiments and induced IpaC surface localiza-
tion in 20% of the observed bacteria. Because the TTSS signal
is located at the IpaC N terminus, an IpaC1–62 mutant lacking
residues 1 to 62 (IpaCI; 21) is not secreted. Thus, as expected,
IpaC1–62 failed to be detected on the S. flexneri surface after
addition of the liposomes (Fig. 2). Although an IpaC176–260
mutant lacking central hydrophilic residues 176 to 260
(IpaCII; 21) exhibits residual invasiveness (10%) in S. flexneri
SF621 (21), the mutant protein did not associate with the S.
flexneri surface (Fig. 2). In contrast, truncations of the C-
terminal portion of IpaC, including IpaC260–363 (IpaCIII; 21)
and IpaC344–363 (an effector region deletion referred to as
1035; 26), did not prevent maintenance of IpaC on the S.
flexneri surface after the addition of erythrocyte-derived lipo-
somes. Similarly, an IpaC62–170 mutant with its hydrophobic
region removed (IpaCH; 21) still associated with the S. flexneri
surface (Fig. 2). This mutant is noninvasive and has greatly
reduced stability and secondary structure content as a purified
recombinant protein (13). However, if the secondary structure
of residues 176 to 260 remains intact, stability may be increased
in vivo by its inclusion as a part of the tip complex. Based on
these findings, it is possible that the central hydrophilic portion
of IpaC is involved in forming a stable interaction with IpaB on
the surface of S. flexneri following contact with host cells.
The importance of liposome composition in IpaC surface
localization. The sheep erythrocyte-derived liposomes that
mobilized IpaC to the S. flexneri surface are reported to have a
high content of SM and Chol (12). With this in mind and to
better define the requirements for IpaC recruitment to the S.
flexneri TTSA surface, defined liposomes composed of DOPC,
SM, and Chol were generated. Indeed, the SM/DOPC/Chol
(1:2:1) liposomes were efficient at promoting the stable recruit-
ment of IpaC to the S. flexneri surface (Fig. 3). This is consis-
tent with work of van der Goot et al. that showed that lipo-
somes rich in SM and Chol induced TTSS-dependent secretion
of IpaB (27).
To further investigate the impact that defined liposomes
have on IpaC surface localization in S. flexneri, a variety of
liposomes prepared using DOPC, DOPG, Chol, or SM or
combinations of these were examined. A summary of those
results is given in Table 1. Although all of the lipids tested were
found to increase IpaC recruitment to the S. flexneri surface,
the results with respect to efficiency of recruitment differed
FIG. 2. Immunofluorescence microscopy (IFM) was used to de-
termine whether different IpaC deletion mutants could be retained
at the S. flexneri surface following incubation with sheep erythro-
cyte-derived liposomes. No IpaC was observed on the surface of S.
flexneri ipaC null strain SF621 bacteria or of bacteria that synthe-
sized IpaC with either an IpaC1–62 or IpaC176–260 deletion mutant.
IpaC260–363, IpaC344–363, and IpaC62–170 deletion mutants all
stained positively for IpaC on the S. flexneri surface after incubation
with liposomes. WT, wild type.
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depending upon the liposome composition (Table 1). Whereas
10% of the bacteria exposed to DOPC or Chol alone exhibited
surface-localized IpaC, nearly 30% of the bacteria incubated
with either SM or mixed liposomes composed of SM/DOPC/
Chol (1:2:1) exhibited IpaC surface localization. These data
suggest an important role for SM in promoting the recruitment
of IpaC to the S. flexneri surface. The particulate nature of the
liposomes is most likely responsible for the relatively small
percentage of bacteria with IpaC detected on their surfaces.
IpaC recruitment to the S. flexneri surface occurs concomi-
tantly with induction of type III secretion. Because SM and
SM/DOPC/Chol liposomes increase the surface localization of
IpaC and because liposomes containing SM and Chol were
previously implicated in type III secretion induction (27), we
examined the effects of the presence of erythrocyte and defined
liposomes on the induced secretion of IpaB and IpaC by iden-
tical numbers of S. flexneri bacteria. As shown in Fig. 4, eryth-
rocyte liposomes induced S. flexneri Ipa protein secretion,
whereas a synthetic liposome mixture of SM/DOPC/Chol in-
duced even greater secretion of Ipa proteins (Fig. 4). Neutral
liposomes consisting only of DOPC had little or no effect on
FIG. 3. Immunofluorescence microscopy (IFM) was used to dem-
onstrate the recruitment of IpaC to the S. flexneri surface in the
presence or absence of liposomes composed of DOPC, SM, and Chol.
The negative control was formed by incubation of bacteria with PBS
plus DOC.
FIG. 4. Immunoblot analysis of IpaB and IpaC secreted by S. flex-
neri in the presence of different liposome types. (A) Results for PBS
plus DOC (the control for uninduced secretion), liposomes derived
from erythrocytes (red blood cells [RBC]), or defined liposomes com-
posed of DOPC, DOPG, SM, and/or Chol. (B and C) Densitometry
scans of IpaB (B) and IpaC (C) present in the immunoblot represented
in panel A provide a quantitative measure of Ipa protein secretion by
S. flexneri in the presence of different lipid preparations. The intensity
of the signal at 680 nm was used to quantify the Alexa Fluor
680-labeled goat anti-rabbit IgG used to detect rabbit anti-IpaB
antibodies. The intensity at 800 nm was used to quantify the Alexa
Fluor 800-labeled goat anti-mouse IgG used to detect mouse anti-
IpaC antibodies.
TABLE 1. The influence of defined liposomes on IpaC recruitment
on the S. flexneri surfacea
Defined liposome contentb % Bacteria with IpaC on thesurface (SD)c
No lipid added (Cntrl) .............................................. 0  0
DOPC.......................................................................... 10.2  5.3
Chol ............................................................................. 10.5  2.7
SM................................................................................ 29.1  8.1
SM/DOPC/Chol.......................................................... 29.7  9.3
a When statistically evaluated utilizing Student’s t tests, IpaC surface localiza-
tion was increased following incubation with either DOPC or Chol containing
liposomes compared to control results (P  0.01). Furthermore, liposomes con-
taining either SM alone or a mixed lipid content of SM, DOPC, and Chol
resulted in a further increase in the percentages of bacteria expressing IpaC
surface localization (P  0.01).
b All bacteria were incubated with DOC prior to the addition of liposomes.
The negative control sample (Cntrl) was incubated with DOC without subse-
quent incubation with liposomes.
c Bacteria having IpaC on their surface were detected by immunofluorescence
microscopy. At least five different random fields from a series of three experi-
ments were counted for total bacteria (approximately 100 bacteria per experi-
ment) and then for bacteria within those fields that stained positively for the
presence of IpaC on their surfaces.
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IpaB or IpaC secretion, but the addition of the acidic lipid
DOPG also increased type III secretion (Fig. 4). When the
data from this representative immunoblot were quantified
(Fig. 4B and C), IpaB and IpaC levels reflected the qualitative
trend represented in Fig. 4A, with the results for IpaC being
the more striking (Fig. 4C). It thus appears that once IpaC is
recruited to the S. flexneri surface, type III secretion is induced
for all the Ipa proteins and, presumably, for the subsequently
secreted TTSS effectors.
IpaC is located at the TTSA needle tip after liposome addi-
tion. We previously used immuno-gold labeling and electron
microscopy to demonstrate that both IpaD and IpaB are asso-
ciated with the TTSA needle tip (7, 19). To confirm that IpaC
localizes to the TTSA needle tip complex upon lipid-induced
type III secretion, this methodology was employed again (Fig.
5). In order to reduce the nonspecific background observed
during the uranyl acetate staining of bacteria after erythrocyte
ghosts or lipids were added, defined liposomes were used to
promote IpaC mobilization. The liposome preparation used
was DOPC/SM/Chol (1:2:1) based on the data presented in
Table 1. Following incubation of bacteria with liposomes, they
were doubly immuno-gold labeled using rabbit anti-IpaB
antibodies with 5-nm-diameter gold-labeled goat anti-rabbit
IgG F(ab)2 for IpaB and mouse monoclonal anti-IpaC an-
tibodies with 10-nm-diameter gold-labeled goat anti-mouse
IgG F(ab)2 for IpaC (Fig. 5). The resulting micrographs show
that IpaB and IpaC are present at the tip of the needles, which
confirms the colocalization shown by immunofluorescence
(Fig. 1). Immuno-gold labeling appears only at the distal end of
the needle structures, suggesting a specific association of these
FIG. 5. Transmission electron microscopy of TTSA needles protruding from the S. flexneri surface (see white arrowheads) after incubation with
liposomes composed of SM, DOPC, and Chol (1:2:1) was used with immuno-gold particle labeling. The presence of 5-nm-diameter gold particles
indicates labeling for IpaB (*) and that of 10-nm-diameter gold particles indicates IpaC labeling (**). No IpaB or IpaC labeling was observed for
an mxiH null mutant (not shown). IpaB labeling but no IpaC labeling was seen for the ipaC null SF621 prior to the addition of liposomes (not
shown).
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proteins following secretion induction. It thus appears that
IpaC, together with MxiH, IpaD, and IpaB, contributes to the
formation of a quaternary complex at the needle tip of the S.
flexneri TTSA following incubation of the bacteria with DOC
and liposomes.
The status of the S. flexneri TTSA needle tip influences the
efficiency of bacterial invasion of HeLa cells. We have now
shown that the maturation process of the TTSA tip complex
occurs in three steps. For step 1, IpaD alone is present at the
needle tip of S. flexneri bacteria grown to the log phase in TSB.
Addition of DOC induces step 2 by mobilizing IpaB to create
the MxiH-IpaD-IpaB ternary tip complex. Here we show that
step 3 is the mobilization of IpaC to the needle tip complex
after incubation of bacteria with the ternary complex on their
surfaces with specific liposomes. To understand the impor-
tance of these needle tip complexes with respect to S. flexneri
invasion of cultured cells, bacteria were grown to the mid-log
phase in TSB, exposed to conditions known to promote either
IpaB or IpaB-IpaC recruitment to the S. flexneri surface, and
then tested for their relative levels of invasion of HeLa cell
monolayers. Since the presence of MEME, like that of DOC,
results in the recruitment of IpaB to the bacterial surface
without inducing type III secretion (unpublished observa-
tions), the gentamicin-protection assay was performed with
HBSS to avoid possible bias in determining the importance of
DOC-induced IpaB surface presentation for S. flexneri inva-
siveness. When the bacteria were incubated for 30 min in the
absence or presence of DOC after growth in TSB, clear dif-
ferences in invasion efficiency were observed (Table 2). The
addition of DOC enhanced S. flexneri invasion more than
threefold, indicating that the DOC-mediated recruitment of
IpaB to the TTSA needle tip resulted in the formation of a
productive complex at the tip of the TTSA needle and that the
ternary complex is important in host cell invasion (Table 2).
This finding supports the proposal that the ternary complex
present on the S. flexneri surface is physiologically relevant.
Thus, the DOC-mediated events represent the second step in
TTSA complex maturation and may be a prerequisite step for
type III secretion induction.
The MxiH-IpaD-IpaB complex appears to represent the ma-
ture tip complex that is required for optimally productive host
cell contact. Thus, the subsequent membrane-IpaB interaction
would logically represent the type III secretion trigger that
promotes IpaC recruitment to the TTSA needle tip and the
simultaneous injection of IpaB and IpaC into the host cell
membrane and cytoplasm. If this is the case, when IpaC local-
izes prematurely to the tip, interaction with the host cell would
no longer be optimal and there would be a reduction in inva-
sion. In line with this, when the bacteria were incubated in
DOC combined with the DOPC/SM/Chol liposomes, invasion
levels still increased relative to those seen with S. flexneri in-
cubated in the absence of any supplement; however, the levels
were reduced relative to those seen with bacteria incubated
with DOC alone (Table 2). When known artificial inducers of
S. flexneri type III secretion, namely, CR and serum, were
incubated with the bacteria (with no DOC present), invasion
levels also decreased relative to the levels seen with the DOC
control (Table 2). In fact, incubation with serum decreased
invasion levels to below those seen without DOC. Based on
these findings, it is possible to suggest that the optimal TTSA
tip complex for S. flexneri invasion of cultured cells is the
ternary complex that includes MxiH, IpaD, and IpaB. The
subsequent induction and secretion of IpaC comprise the final
step in triggering the induction of full type III secretion.
DISCUSSION
IpaD represents the first protein found to localize to the tip
of the S. flexneri TTSA needle, where it is involved in control-
ling secretion and further tip assembly (7). IpaB subsequently
associates with the needle tip complex (7), but only after in-
cubation of the bacteria with certain small molecules such as
those of bile salts (19) and those found in MEME (unpub-
lished observations). It is noteworthy that the bile salt concen-
tration in the gut lumen greatly exceeds that needed to trigger
IpaB mobilization. The fact that tissue invasion occurs in the
colon rather than where bile salt concentrations are highest (in
the small intestine) suggests that additional factors contribute
to the ultimate selection of the colon as the infection site. It
should be noted, however, that conditions that promote the
completion of the IpaD-IpaB tip complex do not result in type
III secretion induction and do not give rise to detectable levels
of IpaC on the bacterial surface (19). In contrast, these con-
ditions do lead to optimal invasion efficiency. Thus, the MxiH-
IpaD-IpaB ternary complex appears to represent the physio-
logically relevant complex that senses contact with the host cell
and triggers subsequent invasion.
Another argument for the proposal that IpaC is not needed
for initial TTSA interaction with host cells stems from past
observations that the ipaC null mutant SF621 strain is capable
of eliciting detectable levels of contact hemolysis whereas ipaD
and ipaB null mutants do not lead to any detectable contact
hemolysis, despite the fact that they are constitutive for type III





Control A Control B
SF621 (ipaC null) None 0  0 0  0
SF621  ipaC None 100  13 NAe
SF621  ipaC DOC 319  3 100  1
SF621  ipaC DOC  lipidsd 246  8 77  3
SF621  ipaC 0.07% Congo red 132  24 41  7
SF621  ipaC 10% serum 71  17 22  5
a Student’s t tests were performed in order to statistically evaluate the results.
Although the addition of serum or Congo red did not result in an increase in the
relative invasiveness of the S. flexneri bacteria compared to the control, the
addition of either DOC alone or DOC plus lipids increased invasiveness com-
pared to the results seen with any of the other populations (P  0.01).
b Bacteria were grown in TSB to an A600 of 1.0 and then placed into TSB
containing the supplements shown for 30 min. The bacteria were then used
directly for invasion of HeLa cells in HBSS for 30 min. The data shown represent
the results obtained with an average of three samples from one of three repre-
sentative experiments.
c Invasion values are presented relative to those determined for S. flexneri
SF621 complemented for ipaC expression and grown as described above and
then incubated in TSB with no additional supplement (Control A). The values
for relative invasion with respect to Control B represent bacteria incubated for
30 min in TSB containing DOC.
d The liposomes used here were a mixture of SM, DOPC, and Chol (see Fig.
3 and 5) to give maximal surface localization of IpaC and secretion of IpaB and
IpaC.
e NA, not applicable.
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secretion (15, 16). This finding is explained by the fact that
IpaD is needed for IpaB maintenance at the TTSA needle tip
and IpaB is needed for initial interaction with the host cell
membrane, perhaps via the Chol-binding activity of IpaB (10,
19), its interaction with raft-associated proteins such as CD44
(14), or interactions involving SM. Meanwhile, the ipaC null
mutant fails to allow the formation of the full translocon pore,
thus preventing the incorporation of the first major S. flexneri
effectors needed for initial invasion-related events (26). This is
consistent with IpaB sensing host cell membrane contact by
inserting itself into the host membrane and simultaneously
promoting the insertion of IpaC into the membrane to com-
plete translocon pore formation as type III secretion is in-
duced. This, in turn, is consistent with the observation that in
the majority of obtained micrographs, it appears that IpaC is
distal to IpaB in relation to the bacterial surface. This suggests
a specific order to the needle tip complex (see Fig. 5B, D, and
G); however, this proposal requires confirmation. The data
presented in Fig. 2 may also show that the hydrophilic region
of IpaC is required for its interaction with IpaB at the TTSA
needle tip, but this interpretation is speculative at present.
We show here that incubation of S. flexneri with SM/Chol-
containing liposomes induces the recruitment of IpaC to the
TTSA needle tip. This appears to occur as the final step in the
induced secretion of IpaB and IpaC into the extracellular en-
vironment, since detection of IpaC on the bacterial surface
occurs concomitantly with full induction of type III secretion.
The fact that liposome preparations that roughly mimic the
composition found in lipid rafts (27) are able to stimulate full
secretion suggests that this event normally occurs upon contact
with a host cell. While treatment of S. flexneri with DOC and
the SM/DOPC/Chol liposomes resulted in elevated invasion
relative to untreated bacteria, invasion was reduced relative to
that seen when the cells were preincubated with only DOC.
This suggests that IpaB is at the TTSA needle tip prior to host
cell contact whereas IpaC is inserted directly into the host cell
membrane immediately following host cell contact. Premature
release of IpaC, as caused by adding liposomes, therefore
decreases overall invasion efficiency. It is possible that the
reduced invasiveness is due to the fact that the MxiH-IpaD-
IpaB-IpaC quaternary complex is the physiologically relevant
needle tip “invasion complex” that is present only following
host cell contact. Premature formation of this complex (prior
to actual contact with a host cell) could give rise to a dead-end
complex that cannot efficiently promote invasion. The possi-
bility cannot be ruled out, however, that incubation of S. flex-
neri with lipids leads to depolarized type III secretion which
could impair the proper targeting of effectors and cause a
reduction in the observed levels of invasion.
From the findings presented here and in previous work, we
propose that the complete S. flexneri TTSA is built in a step-
wise manner. Upon completion of needle formation, IpaD
localizes to the needle tip, where it serves as an environmental
sensor for the mobilization of IpaB and formation of the
MxiH-IpaD-IpaB ternary complex. It is this complex that then
senses host cell contact to promote the simultaneous insertion
of IpaB and IpaC into the target cell membrane and induc-
tion of type III secretion of effectors. Because of the large
amounts of IpaB and IpaC that are secreted upon incubation
with liposomes and because of the highly apolar nature of
these proteins, it will be difficult to determine a precise struc-
ture for the MxiH-IpaD-IpaB-IpaC quaternary structure. It
may be possible, however, to more closely examine the struc-
ture of the preinduction states of the TTSA needle tip to
determine the structural and functional features of these com-
plexes and to dissect the molecular basis for the stepwise in-
duction of type III secretion in S. flexneri.
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VOL. 77, 2009 IpaC LOCALIZES TO THE SHIGELLA TTSA NEEDLE TIP 2761
